Allen Nissenson is Director of Angion Biomedica Corp.. Currently has a direct ownership of 9,383 shares of ANGN, which is worth approximately $0. The most recent transaction as insider was on May 20, 2022, when has been sold 2,037 shares (Common Stock) at a price of $1.18 per share, resulting in proceeds of $2,404. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.38K
0% 3M change
0% 12M change
Total Value Held $0

Allen Nissenson Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2022
BUY
Open market or private purchase
$2,404 $1.18 p/Share
2,037 Added 17.84%
9,383 Common Stock
May 19 2022
BUY
Open market or private purchase
$8,521 $1.16 p/Share
7,346 Added 50.0%
7,346 Common Stock

Also insider at

RMTI
ROCKWELL MEDICAL, INC. Healthcare
AN

Allen Nissenson

Director
Wixom, MI

Track Institutional and Insider Activities on ANGN

Follow Angion Biomedica Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANGN shares.

Notify only if

Insider Trading

Get notified when an Angion Biomedica Corp. insider buys or sells ANGN shares.

Notify only if

News

Receive news related to Angion Biomedica Corp.

Track Activities on ANGN